产品编号 | CFN91741 | |
CAS编号 | 145-42-6 | |
分子式 = 分子量 | C26H44NNaO7S = 537.7 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Steroids | |
植物来源 | ||
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
牛磺胆酸钠 | CFN91741 | 145-42-6 | 10mg | QQ客服:1413575084 |
牛磺胆酸钠 | CFN91741 | 145-42-6 | 20mg | QQ客服:1413575084 |
牛磺胆酸钠 | CFN91741 | 145-42-6 | 50mg | QQ客服:1413575084 |
牛磺胆酸钠 | CFN91741 | 145-42-6 | 100mg | QQ客服:1413575084 |
Description: | Sodium taurocholate has marked bioactive effects such as an inhibitory potential against hepatic artery ligation induced biliary damage by upregulation of VEGF-A expression. Sodium taurocholate has immunoregulation effect. IC50 & Target:Microbial Metabolite; Human Endogenous Metabolite |
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.8598 mL | 9.2989 mL | 18.5977 mL | 37.1955 mL | 46.4943 mL |
5 mM | 0.372 mL | 1.8598 mL | 3.7195 mL | 7.4391 mL | 9.2989 mL |
10 mM | 0.186 mL | 0.9299 mL | 1.8598 mL | 3.7195 mL | 4.6494 mL |
50 mM | 0.0372 mL | 0.186 mL | 0.372 mL | 0.7439 mL | 0.9299 mL |
100 mM | 0.0186 mL | 0.093 mL | 0.186 mL | 0.372 mL | 0.4649 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
2,4,6-三甲氧基苯酚 1-O-beta-D-吡喃葡萄糖苷; 2,4,6-Trimethoxyphenol 1-O-beta-D-glucopyranoside | CFN99366 | 125288-25-7 | C15H22O9 = 346.3 | 5mg | QQ客服:215959384 |
6,8-Di-O-methylcitreoisocoumarin; 6,8-Di-O-methylcitreoisocoumarin | CFN89086 | 908098-80-6 | C16H18O6 = 306.31 | 5mg | QQ客服:215959384 |
PD0325901(Mirdametinib); PD0325901(Mirdametinib) | CFN60032 | 391210-10-9 | C16H14F3IN2O4 = 482.19 | 5mg | QQ客服:2159513211 |
鱼藤素; Deguelin | CFN97934 | 522-17-8 | C23H22O6 = 394.4 | 5mg | QQ客服:1413575084 |